CGEM

SEC source: 0000950170-24-078678 · ownership.xml · derivative · entry 1

Webster Stephen W · CIK 0001438421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,806

Underlying: Common Stock · 15,806 shares

Expires 2034-06-26

F1 · derivative.exercise_date: The option represents a right to purchase a total of 15,806 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 26, 2025 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.

SEC source: 0000950170-24-078676 · ownership.xml · derivative · entry 1

Martin Anne-Marie · CIK 0001914495 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,806

Underlying: Common Stock · 15,806 shares

Expires 2034-06-26

F1 · derivative.exercise_date: The option represents a right to purchase a total of 15,806 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 26, 2025 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.

SEC source: 0000950170-24-078675 · ownership.xml · derivative · entry 1

Ryan David P. · CIK 0001951490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,806

Underlying: Common Stock · 15,806 shares

Expires 2034-06-26

F1 · derivative.exercise_date: The option represents a right to purchase a total of 15,806 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 26, 2025 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.

SEC source: 0000950170-24-072095 · ownership.xml · derivative · entry 2

Ebeling Thomas · CIK 0001297759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,450 shares

Expires 2033-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-072095 · ownership.xml · nonDerivative · entry 1

Ebeling Thomas · CIK 0001297759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,653

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-063948 · ownership.xml · derivative · entry 4

Ebeling Thomas · CIK 0001297759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,475 shares

Expires 2032-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-063948 · ownership.xml · derivative · entry 3

Ebeling Thomas · CIK 0001297759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 84,224 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the shares vested on August 16, 2018, and the remaining shares vested in 36 equal monthly installments thereafter.

SEC source: 0000950170-24-063948 · ownership.xml · nonDerivative · entry 2

Ebeling Thomas · CIK 0001297759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,203

SEC source: 0000950170-24-063948 · ownership.xml · nonDerivative · entry 1

Ebeling Thomas · CIK 0001297759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,728

SEC source: 0000950170-24-061228 · ownership.xml · derivative · entry 1

Meek David D. · CIK 0001555337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,618

Underlying: Common Stock · 15,618 shares

Expires 2034-05-15

F1 · derivative.exercise_date: The option represents a right to purchase a total of 15,618 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date.

SEC source: 0000950170-24-056093 · ownership.xml · derivative · entry 7

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,987

Underlying: Common Stock · 5,606 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares vested on July 4, 2020, and the remaining shares vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0000950170-24-056093 · ownership.xml · nonDerivative · entry 5

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,582

F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-056093 · ownership.xml · nonDerivative · entry 4

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,188

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-056093 · ownership.xml · derivative · entry 6

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,593

Underlying: Common Stock · 50,000 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares vested on July 4, 2020, and the remaining shares vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC source: 0000950170-24-056093 · ownership.xml · nonDerivative · entry 3

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,582

F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.35 to $28.84. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-056093 · ownership.xml · nonDerivative · entry 2

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 149,859

F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.35 to $28.34. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-056093 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-050844 · ownership.xml · derivative · entry 1

Fenton Mary Kay · CIK 0001378589 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-04-29

F1 · derivative.exercise_date: The option represents a right to purchase a total of 200,000 shares of the Issuer's Common Stock, 25% of which will become vested and exercisable on April 29, 2025, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

SEC source: 0000950170-24-019462 · ownership.xml · derivative · entry 2

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,000

Underlying: Common Stock · 320,000 shares

Expires 2034-02-22

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

SEC source: 0000950170-24-019462 · ownership.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,550

F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years.

SEC source: 0000950170-24-019463 · ownership.xml · derivative · entry 2

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2034-02-22

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

SEC source: 0000950170-24-019463 · ownership.xml · nonDerivative · entry 1

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,490

F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years.

SEC source: 0000950170-24-019458 · ownership.xml · derivative · entry 2

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-02-22

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

SEC source: 0000950170-24-019458 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,919

F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years.

SEC source: 0000950170-24-019455 · ownership.xml · derivative · entry 2

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-02-22

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

SEC source: 0000950170-24-019455 · ownership.xml · nonDerivative · entry 1

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,691

F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years.

SEC source: 0000950170-24-019456 · ownership.xml · derivative · entry 2

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-02-22

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

SEC source: 0000950170-24-019456 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,582

F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years.

SEC source: 0000950170-24-019457 · ownership.xml · derivative · entry 2

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-02-22

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

SEC source: 0000950170-24-019457 · ownership.xml · nonDerivative · entry 1

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,133

F1 · shares: The shares underlying the restricted stock unit vest on an annual basis over four years.

SEC source: 0000950170-24-010975 · ownership.xml · derivative · entry 3

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,331

Underlying: Common Stock · 40,000 shares

Expires 2030-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares vested on September 1, 2019, and the remaining shares vested in 36 equal monthly installments thereafter, becoming fully vested and exercisable on September 1, 2022.

SEC source: 0000950170-24-010975 · ownership.xml · nonDerivative · entry 2

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,990

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.52. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-010975 · ownership.xml · nonDerivative · entry 1

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,990

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-009047 · ownership.xml · derivative · entry 4

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,331

Underlying: Common Stock · 26,003 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares vested on September 1, 2019, and the remaining shares vested in 36 equal monthly installments thereafter, becoming fully vested and exercisable on September 1, 2022.

SEC source: 0000950170-24-009047 · ownership.xml · derivative · entry 3

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,997 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares vested on May 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter, becoming fully vested and exercisable on May 4, 2023.

SEC source: 0000950170-24-009047 · ownership.xml · nonDerivative · entry 2

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,990

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.54. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-009047 · ownership.xml · nonDerivative · entry 1

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,990

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-007032 · ownership.xml · derivative · entry 7

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,997

Underlying: Common Stock · 21,316 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares vested on May 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter, becoming fully vested and exercisable on May 4, 2023.

SEC source: 0000950170-24-007032 · ownership.xml · nonDerivative · entry 5

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,990

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.60. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-007032 · ownership.xml · nonDerivative · entry 4

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-007032 · ownership.xml · derivative · entry 6

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,313

Underlying: Common Stock · 14,559 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 25% of the shares vested on May 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter, becoming fully vested and exercisable on May 4, 2023.

SEC source: 0000950170-24-007032 · ownership.xml · nonDerivative · entry 3

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,990

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.09. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-007032 · ownership.xml · nonDerivative · entry 2

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,115

F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.44. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-24-007032 · ownership.xml · nonDerivative · entry 1

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-23-073405 · ownership.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,550

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

SEC source: 0000950170-23-072756 · ownership.xml · nonDerivative · entry 1

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,191

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

SEC source: 0000950170-23-072755 · ownership.xml · nonDerivative · entry 1

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,133

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.49 to $8.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-23-072754 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,919

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

SEC source: 0000950170-23-072753 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,582

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

SEC source: 0000950170-23-071987 · ownership.xml · nonDerivative · entry 1

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,051

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.